Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emanuele Ravano
Observed name:
E. Ravano
Institution:
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
Observed institutions:
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
ORCID:
0009-0000-3284-8768
Observed ORCID:
0009-0000-3284-8768
OpenAlex ID:
A5063520292
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results
2024
·
Maurizio Martelli
, Luca Ceriani
, et al.
·
Journal of Clinical Oncology
·
44
Hematological improvement during iron-chelation therapy in myelodysplastic syndromes: The experience of the “Rete Ematologica Lombarda”
2013
·
Alfredo Molteni
, Marta Riva
, et al.
·
Leukemia Research
·
22
Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients.
2024
·
Arianna Zappaterra
, Ivan Civettini
, et al.
·
Blood transfusion
·
13
PDF
MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study
2024
·
Chiara Pagani
, Chiara Rusconi
, et al.
·
Blood Advances
·
12
PDF
Dual antiviral therapy in haematological patients with protracted SARS‐C o V ‐2 infection
2023
·
F. Peracchi
, M. Merli
, et al.
·
British Journal of Haematology
·
8
PDF
Prognostic Impact of Immunohistochemical P53 Expression in Bone Marrow Biopsy in Higher Risk Mds: a Pilot Study
2019
·
Alfredo Molteni
, Emanuele Ravano
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
·
8
PDF
Clofarabine-based chemotherapy as a bridge to transplant in the setting of refractory or relapsed acute myeloid leukemia, after at least one previous unsuccessful salvage treatment containing fludarabine: a single institution experience
2017
·
Alfredo Molteni
, Marta Riva
, et al.
·
International Journal of Hematology
·
8
The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the “Rete Ematologica Lombarda”
2016
·
Alfredo Molteni
, Marta Riva
, et al.
·
Leukemia Research
·
8
Validating the Patient's "Fitness" Criteria Proposed to Guide Treatment Decision in Elderly AML: a Multicenter Study on a Population-Based Series of 362 Patients By the Network "Rete Ematologica Lombarda" (REL)
2014
·
Erika Borlenghi
, Chiara Pagani
, et al.
·
Blood
·
5
Prognostic relevance of the flow cytometric count of medullar blasts in myelodysplastic syndromes
2014
·
Alfredo Molteni
, Marta Riva
, et al.
·
European Journal Of Haematology
·
4
Verifying Hellström-Lindberg score as predictive tool for response to erythropoietin therapy according to the “International Working Group” criteria, in anemic patients affected by myelodysplastic syndrome: a monocentric experience
2013
·
Alfredo Molteni
, Marta Riva
, et al.
·
International Journal of Hematology
·
4
Primary Mediastinal B‐cell Lymphoma, a nationwide real‐life retrospective study from Fondazione Italiana Linfomi (FIL)
2023
·
E. Iannitto
, M. Balzarotti
, et al.
·
Hematological Oncology
·
3
PDF
Current Treatment Options and the Role of Functional Status Assessment in Classical Hodgkin Lymphoma in Older Adults: A Review
2023
·
Vittorio Ruggero Zilioli
, Cristina Muzi
, et al.
·
Cancers
·
3
PDF
A double‐hit High‐grade B‐cell lymphoma with three‐way translocation t(3;8;14)(q27;q24;q32) involving BCL6, MYC, and IGH
2018
·
Elena De Paoli
, Laura Bandiera
, et al.
·
Clinical Case Reports
·
3
PDF
Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network
2018
·
Patrizia Zappasodi
, Laura Marbello
, et al.
·
Annals of Hematology
·
3
Feasibility of all-oral anti-HCV treatment during DHAP chemotherapy and autologous stem cell transplantation for T-cell lymphoma.
2018
·
Roberto Rossotti
, Chiara Rusconi
, et al.
·
PubMed
·
3
T-cell receptor gene rearrangement in Epstein–Barr virus infectious mononucleosis
2011
·
L. Marbello
, M. Riva
, et al.
·
Medical Oncology
·
3
Intrahospital COVID‐19 infection outbreak management: Keep calm and carry on
2021
·
Anna M. Frustaci
, Maria L. Pioltelli
, et al.
·
Hematological Oncology
·
2
PDF
Danazol Treatment for Thrombocytopenia in Lower-Risk Myelodysplastic Syndromes: A Pilot Real Life Experience
2018
·
Marta Riva
, Lara Crucitti
, et al.
·
Blood
·
2
Corrigendum to ‘Hematological improvement during iron-chelation therapy in myelodysplastic syndromes: The experience of the “Rete Ematologica Lombarda”’ [Leuk Res 37 (2013) 1233–1240]
2013
·
Alfredo Molteni
, Marta Riva
, et al.
·
Leukemia Research
·
2
Daratumumab in combination with GDP chemotherapy in CD38-positive relapsed/refractory peripheral T-cell lymphoma: a phase 2 study of the Fondazione Italiana Linfomi
2026
·
Mario Ballerini
, Elisa Lucchini
, et al.
·
Annals of Hematology
·
1
Ibrutinib plus R-CHOP followed by maintenance in untreated ABC-DLBCL patients with IPI ≥2: A first analysis of phase II Study FIL_RI-CHOP
2025
·
Alice Di Rocco
, Annalisa Chiappella
, et al.
·
Blood
·
1
PDF
Description of a Clinical Score to Identify PMBL Patients at High Risk of Early-Failure after Rituximab Doxorubicin Back-Bone Chemoimmunotherapy. a FIL Real-World Study
2023
·
Emilio Iannitto
, Monica Balzarotti
, et al.
·
Blood
·
1
PDF
Decisional Role of Interim PET in Relapsed/Refractory Classical Hodgkin Lymphoma Treated with Begev Chemotherapy As First Salvage
2022
·
Chiara Rusconi
, Francesca Ricci
, et al.
·
Blood
·
1
The Immunohistochemical Expression of p53 in Bone Marrow Biopsy Has Unfavorable Prognostic Impact in Higher Risk Myelodysplastic Syndromes If It Is at Least 10%
2016
·
Alfredo Molteni
, Emanuele Ravano
, et al.
·
Blood
·
1
Show more works
View as search
Works count:
52
Citation count:
168
H-index:
8
I10-index:
4
Year
Topic
Type